Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens

12 May 2006

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Disease Management and Epidemiology
Share to Immune Response and Inflammation
Share to Influenza Virus Research Studies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 16690097
DOI: 10.1016/j.virol.2006.01.044

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickensPMID 16690097Read ↗

Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse geneticsSemantic proximity Read ↗

Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccineSemantic proximity Read ↗

Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickensSemantic proximity Read ↗

Evaluation of avian influenza virus isolated from ducks as a potential live vaccine candidate against novel H7N9 virusesSemantic proximity Read ↗

Protective efficacy of an H5/H7 trivalent inactivated vaccine produced from Re-11, Re-12, and H7-Re2 strains against challenge with different H5 and H7 viruses in chickensSemantic proximity Read ↗

Recombinant Marek’s disease virus type 1 provides full protection against H9N2 influenza A virus in chickensSemantic proximity Read ↗

Development of DIVA (differentiation of infected from vaccinated animals) vaccines utilizing heterologous NA and NS1 protein strategies for the control of triple reassortant H3N2 influenza in turkeysSemantic proximity Read ↗

Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insertSemantic proximity Read ↗

WITHDRAWN: Evaluation of immunity and protection in chicken administered a developed vaccine against predominant Middle Eastern strains of genotypes VI and VII of velogenic Newcastle Disease VirusSemantic proximity Read ↗

Single dose of multi-clade virus-like particle vaccine protects chickens against clade 2.3.2.1 and clade 2.3.4.4 highly pathogenic avian influenza virusesSemantic proximity Read ↗

Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza virusesSemantic proximity Read ↗

Avian influenza vaccines and therapies for poultrySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.